Popular search terms:
Search Results Label
34 results found-
Seqirus announces major advances in pandemic preparedness
Seqirus announced today that the accelerated development of cell-based manufacturing technology at its manufacturing facility in Holly Springs, North Carolina, has delivered a four-fold increase in seasonal influenza vaccine output in just two years, strengthening the United States' capacity to respond to pandemic threats.
https://www.seqirus.com/...advances-in-pandemic-preparedness -
Seqirus | Influenza Expertise
Seqirus brings multifaceted expertise to influenza prevention, employing both egg and cell-based technologies to meet the global community's needs.
https://www.seqirus.com/expertise -
Seqirus announces next major advancement in cell-based influenza
In an industry first, Seqirus has successfully produced cell-based influenza vaccine at commercial scale using a candidate vaccine virus (CVV) that has been isolated and grown in cells, rather than in eggs.
https://www.seqirus.com/...ased-influenza-vaccine-technology -
Seqirus Applauds the Executive Order to Accelerate Enhanced Protection
Read the latest news from Seqirus, a world leader in developing and producing influenza vaccines.
https://www.seqirus.com/...tection-against-influenza-threats -
Microsoft Word - Seqirus Methodological Statement for EFPIA
Seqirus is a transcontinental partner in pandemic preparedness, and a major contributor to the prevention and control of influenza globally, with extensive research and production
https://www.seqirus.com/-/media/seqirus/pdfs/seqirus-methodological-statement-for-abpi--updated-14-march-20170.pdf -
Seqirus Methodological Statement for EFPIA
Seqirus is a transcontinental partner in pandemic preparedness, and a major contributor to the prevention and control of influenza globally, with extensive research and production
https://www.seqirus.com/-/media/seqirus/pdfs/seqirus-methodological-statement-for-efpia-2015.pdf -
Seqirus Methodological Statement for EFPIA CY2017
Seqirus is a transcontinental partner in pandemic preparedness, and a major contributor to the prevention and control of influenza globally, with extensive research and production
https://www.seqirus.com/-/media/seqirus/pdfs/seqirus-methodological-statement-for-efpia-cy2017.pdf -
Microsoft Word - Seqirus Methodological Statement for EFPIA CY2018
Seqirus is a transcontinental partner in pandemic preparedness, and a major contributor to the prevention and control of influenza globally, with extensive research and production
https://www.seqirus.com/-/media/seqirus/pdfs/seqirus-methodological-statement-for-efpia-cy2018.pdf -
Seqirus | A World Leader in Influenza Vaccines
Learn more about how we're leveraging cutting-edge technology and proven expertise to develop influenza vaccines and respond to pandemic threats.
https://www.seqirus.com/ -
Seqirus | Global Manufacturing Network
Seqirus is one of the largest influenza vaccine companies in the world, with state-of-the-art manufacturing facilities on three continents. Learn more.
https://www.seqirus.com/...ring/global-manufacturing-network